Page 55 - Quantitative Imaging of Small Tumours with Positron Emission Tomography
P. 55
Chapter 2 54 Supplemental Table 2.2: VOI method feasibility (% of 70 lesions successfully delineated) and median SUVmean and TLG for all combinations of VOI and PVC method of the 18F-FDG-PET cohort. *numbers in parentheses represent IQR. VOI PVC feasibility (% of 70) Scan 1 Median SUVmean* Median TLG* feasibility (% of 70) Scan 2 Median SUVmean* Median TLG* 42MAX Uncorrected IDC-LR 81.4 6.2 (3.5) 8.2 (6.2) 9.1 (8) 8.8 (6) 9.2 (7) 7.4 (3.9) 6.8 (3.5) 9.5 (7) 11.2 (9.6) 10.5 (7.8) 10.1 (7.1) 8.1 (4.6) 6.7 (3.5) 9.9 (6.4) 13.4 (8.1) 11 (6.9) 10.1 (6.3) 8.1 (4.3) 7.4 (3.8) 10.3 (6.1) 17.6 (10.7) 14 (8.9) 10.1 (5.7) 9 (4.7) 41.8 (211.2) 57.6 (245.8) 65.3 (304.5) 63.8 (264) 67.1 (269.2) 36.4 (225.1) 28.4 (165.8) 44 (194.7) 60.5 (242.6) 50.5 (224.8) 46.9 (210.8) 21.4 (145.6) 18.9 (131.2) 30.4 (161.8) 54.5 (206.5) 35.9 (181.9) 29.9 (175.1) 17.7 (109) 13.4 (59.8) 19.9 (71) 81.4 5.9 (3.9) 7.7 (5.9) 9.4 (7.2) 8.5 (6.6) 9.3 (7.2) 7.3 (4.6) 6.3 (4.4) 8.7 (6.7) 12.2 (11.4) 10.5 (8.2) 9.9 (7.5) 7.9 (5.4) 6.4 (4.1) 9.1 (5.4) 13.1 (6.7) 11.3 (6.2) 9.5 (5.6) 7.8 (5) 42.1 (234.2) 54.6 (264.9) 73.6 (310.6) 61.6 (277.6) 64.8 (282.8) 37.9 (215) 27.8 (156.4) 38.6 (193.6) 60.8 (254.7) 47 (217.2) 42.1 (214.7) 18.6 (112.7) 18.9 (77.5) 29.5 (93.7) 43.4 (185.8) 34 (118.1) 29.1 (99.6) 19.5 (54.3) 13.9 (37.8) 19 (43.7) 40.5 (124.5) 30.2 (71.9) 19.7 (47.9) 13.7 (31.6) 50MAX Uncorrected IDC-LR A42MAX Uncorrected IDC-LR A50MAX Uncorrected IDC-LR 7 (4.4) 9.4 (5.3) 19.5 (12.7) 15.2 (8.1) 10.3 (5.7) 8.8 (5.3) HH-GLBL HH-LCL Spill-over PSF 92.9 94.3 88.6 84.3 HH-GLBL HH-LCL Spill-over PSF 97.1 94.3 91.4 91.4 HH-GLBL HH-LCL Spill-over PSF 97.1 97.1 95.7 91.4 HH-GLBL HH-LCL Spill-over PSF 100.0 41 (164.5) 30.1 (100.6) 19.3 (75.1) 12.4 (34.2) 94.3
